Back to 
Carlyle Group Inc.
Carlyle Group Inc.
VERAShowing 0 of 5 quarters
Position history for Carlyle Group Inc.'s holdings in VERA THERAPEUTICS INC
No. Carlyle Group exited its VERA (Vera Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 1,438,155 shares worth $22.1M. Carlyle Group first reported VERA in Q1 2023 and held it in 4 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of VERA: Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc.